Service | Details | Compliance | Suppliers |
Select a relevant service
To better assist you with your request, please choose a research area provided by Partners 4 Access. In case you cannot find an exact match, simply select any service, and our concierge team will swiftly address it once your request has been submitted.
-
Market Access
Find general strategies and methods used to market a pharmaceutical product or device.
-
Market Research & Business Intelligence
Run market feasibility studies, establish customer needs, improve product performance and analyze competition.
-
Pricing Strategy
Develop value story tailored to a payer audience that will determine the appropriate price for treatment.
-
Value Dossiers Development
Summary document that presents clinical, economic, and humanistic value of an intervention and associated disease state with the supporting evidence, formulated from the perspective of a particular stakeholder (manufacturer, payer, provider, HTA agency, etc.). See also HTA Submission.
-
Health Technology Assessment Submission (HTA Submission)
Analyze the medical, social, ethical, humanistic, and economic considerations of a drug, medical device, or clinical procedures. Submissions are sent to regulatory agencies with different requirements that govern submissions. See also AMCP and Value Dossier.
-
Formulary & Reimbursement Strategy
Develop strategy and narrative to gain formulary access on insurance plans.
-
Value Based Agreements or Outcomes-Based Contracts
Collaborate with payer or provider to develop a reimbursement plan outside of the traditional fixed cost-per-unit that ties reimbursement or price to actual health outcomes.
-
Emerging Market Opportunities
Analyze risks and opportunities in new markets and ensure patients have timely and continued access to new treatments.
-
Life Cycle Management
Plan and strategy of the data collection and information throughout the different phases of product development (portfolio assessment, pre-clinical trials, clinical trials, pre-authorization, post-authorization, and RWE)
-
Health Technology Assessment
Conduct a multidisciplinary process that determines the value of a health technology through different points in its lifecycle.